Franck Perez (@team_franckp) 's Twitter Profile
Franck Perez

@team_franckp

ID: 989410904549871616

calendar_today26-04-2018 07:48:36

126 Tweet

481 Followers

119 Following

Franck Perez (@team_franckp) 's Twitter Profile Photo

Congratulation to Danijela Vignjevic Danijela Matic Vignjevic Institut Curie #UMR144 for her election at EMBO . A well-deserved recognition to a great scientists and a super colleague & friend !

Basto_Lab (@basto_lab) 's Twitter Profile Photo

Our review about polyploidy and its link with genetic instability is now available on Pubmed. Have a look! CHRONOCRISIS: When Cell Cycle Asynchrony Generates DNA Damage in Polyploid Cells onlinelibrary.wiley.com/doi/full/10.10…

Our review about polyploidy and its link with genetic instability is now available on Pubmed. Have a look! 
CHRONOCRISIS: When Cell Cycle Asynchrony Generates DNA Damage in Polyploid Cells
onlinelibrary.wiley.com/doi/full/10.10…
Honing Biosciences (@honingbio) 's Twitter Profile Photo

Very happy to highlight the talk of Zelia Gouveia from @honingBio at AISCongress Zelia will show how Honing's #CELLTune technology can be used to modulate cell-based therapies. #cancer #cartcell #immunotherapy #celltherapy

Franck Perez (@team_franckp) 's Twitter Profile Photo

Pour les 30 ans de la Fête de la Science Fête de la science et l'« Année de la biologie au CNRS 🌍», les unités de « Physico-Chimie » et de « Biologie Cellulaire et Cancer » de l'Institut Curie vous accueillent. Demandez le programme ! bit.ly/2ZJmga2

SBCF (@sbcf1) 's Twitter Profile Photo

The SBCF is happy to announce the election of its new president, Florence Niedergang, new vice-president Isabelle TardieuXlab, new treasurer Benedicte Delaval and three new board members Benjamin Lacroix, Stephanie Lebreton and Christel Vérollet! 👏 Next General assembly on June 3rd!

Franck Perez (@team_franckp) 's Twitter Profile Photo

Happy to share with you our last study done in collaboration with Arnaud Gautier's team (arnaudgautier.com) A novel fluorogenic system enabling fast and reversible recruitment of proteins to alter or sense cellular dynamics.

SBCF (@sbcf1) 's Twitter Profile Photo

After the success of @sbcf1 symposium "The Cell Biology of Neurons and Beyond" last January, you can find now the posters by Akenium 🧪💡✏ describing the invited talks sbcf.fr/en/event/the-c… 🤩🤩

GBM e.V. (@gbm_ev) 's Twitter Profile Photo

📢Here is the english version of our new statement on the draft bill of the #WissZeitVG 👇We have already forwarded our statement to the BMBF. Deadline for feedback to BMBF is July 3, maybe other professional societies will use this opportunity?

📢Here is the english version of our new statement on the draft bill of the #WissZeitVG 👇We have already forwarded our statement to the BMBF. Deadline for feedback to BMBF is July 3, maybe other professional societies will use this opportunity?
Franck Perez (@team_franckp) 's Twitter Profile Photo

We are very happy to announce that a position is now open in the "Cell Biology and Cancer" unit" @UMR144 Institut Curie CNRS 🌍 for a Junior Group Leader. Deadline for proposal: 25th of November 2023. Please, see the attached call and diffuse it !

We are very happy to announce that a position is now open in the "Cell Biology and Cancer" unit" @UMR144 <a href="/institut_curie/">Institut Curie</a> <a href="/CNRS/">CNRS 🌍</a> for a Junior Group Leader. Deadline for proposal: 25th of November 2023. Please, see the attached call and diffuse it !
SBCF (@sbcf1) 's Twitter Profile Photo

🎂🎂SBCF was created 40 years ago ! To mark this milestone we organise a special symposium hosted by Académie des sciences on September 10th! Save the date and register sbcf.fR/en/event/sympo…

Institut Curie (@institut_curie) 's Twitter Profile Photo

L’Institut Curie salue le succès fulgurant de sa spin-off Emglev Therapeutics, acquise par Valerio Therapeutics 👏 Un parcours qui témoigne de la qualité des innovations "made in Curie", source de technologies de rupture au bénéfice des patients. ▶️ curie.fr/actualite/tran…

L’<a href="/institut_curie/">Institut Curie</a> salue le succès fulgurant de sa spin-off Emglev Therapeutics, acquise par Valerio Therapeutics 👏 

Un parcours qui témoigne de la qualité des innovations "made in Curie", source de technologies de rupture au bénéfice des patients.

▶️ curie.fr/actualite/tran…